AVII Financial Facts
Research and development: 34.35MGeneral and administrative: 22.18M
See Full Income Statement
Other current assets: 22M
Total Shareholders' Equity (Deficit): 408.62M
See Full Balance Sheet
AVI Biopharma, Inc. (AVII) Earnings
|
Expand Research on AVII
Next EPS Date | N/A | EPS Growth Rate | N/A |
---|---|---|---|
Average EPS % Beat Rate | +40.5% | Revenue Growth Rate | N/A |
Average % Move 1-Wk after EPS | -1.6% | Normal Earnings Time | After Close |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
11/3/11 | Q311 | -$0.03 | -$0.06 | +$0.03 | N/A | $13.88M | = | Details | |||
8/4/11 | Q211 | $0.01 | -$0.07 | +$0.08 | $11.6M | $13.67M | = | Details | |||
5/5/11 | Q111 | $0.02 | -$0.03 | +$0.05 | $15.3M | $13.55M | = | Details | |||
3/10/11 | Q410 | -$0.07 | -$0.07 | $0.00 | $15.5M | $11.65M | = | Details | |||
5/10/12 | Q112 | -$0.13 | -$0.07 | -$0.06 | $11.2M | $11.05M | = | Details | |||
3/1/12 | Q411 | -$0.01 | -$0.06 | +$0.05 | $13.6M | $11.03M | = | Details |